Biogen Idec Switzerland

Last updated: 12.03.2014

biogen-logoCompany Profile

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. They have additional offices in the US, Canada, Australia, Japan and throughout Europe. Biogen Idec has a direct commercial presence in 29 markets, a network of distribution partners in more than 70 additional markets and operations in several new markets, including Central/Eastern Europe, Brazil, China and India.

Contact Info

Biogen Idec Switzerland AG
Zählerweg 6
CH 6300 Zug
Phone: +41 41 728 7444
Fax: +41 41 728 7440

International Headquarters
Biogen Idec International GmbH
Landis & Gyr-Strasse 3
CH 6300 Zug

Phone: +41 41 39 21700
Fax: +41 41 39 21710


We use cookies to ensure that we give you the best experience on our site. For more info click here